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INTRODUCTION
Cryptostegia grandiflora R.Br. (Asclepiadaceae) is an ornamental plant cultivated in Egypt and warm countries. [1] [2] [3] From its leaves, few cardenolides (cryptograndoside A, B and digitalinum verum) have been already reported. 4 Recently, six more cardenolides (subalpinosid, 16-O-acetyl-digitalinum verum and cryptostigmin I-IV) have been isolated from the leaves of C. grandiflora. 5 The present study deals with the isolation and structure determination of a benzophenone glucoside together with a lignan glucoside and two aliphatic glucosides from the leaves of C. grandiflora in addition to investigation of the cardiotonic activity of the leaves extract and cryptostigmin II previously isolated from this plant.
MATERIAL AND METHODS

Plant material
Leaves of C. grandiflora R.Br. (Asclepiadaceae) were collected from the trees cultivated in the Experimental Station of faculty of Agriculture, Assiut University, Assiut, Egypt, in March 1997. The plant was identified by Prof. N. El-Keltawi, Department of Horticulture, Faculty of Agriculture, Assiut University, Assiut, Egypt. A voucher specimen is deposited at the Herbarium of Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut, Egypt. 1 H and 13 
General experimental procedures
Extraction and Isolation
The air-dried powdered leaves of C. grandiflora (500 mg) were extracted with 70% EtOH. The dried ethanolic extract (125 g) was suspended in H 2 O and defatted successively with n-hexane and CH 2 C-NMR (C 5 D 5 N) as cited in Table 1 . 13 C-NMR 100 MHz (DMSO) as cited in Table 1 . Table 1 .
Evaluation of the effects of Digoxin, Cryptostigmin II and Cryptostegia extract on blood pressure and heart rate 6, 7 Adult male rabbits (1.5-2.5 kg average weight) were used. The rabbits were anesthetized with intraperitoneal injection of 25% urethane solution in a dose of 6.4 ml/kg. Their tracheae were cannulated for artificial respiration when necessary. The right femoral vein was cannulated for intravenous injection of the tested samples. The arterial blood pressure was recorded via the carotid artery which was connected to a PT 400 Blood Pressure Transducer and an amplifier of a twochannel oscillograph MD2 (Bioscience, Kent, UK). The transducer was then calibrated and the electrocardiographic changes were simultane-ously recorded using standard lead II. The changes in blood pressure and heart rate of rabbits were recorded before and at 15, 30, 60 and 90 min after intravenous injection of the different doses from the sample solution in normal saline. The obtained results are recorded in Tables 1 and 2 .
Evaluation of the effects of Digoxin, Cryptostigmin II and Cryptostegia extract on the contractility of the isolated perfused rabbit's heart
The isolated hearts were prepared for perfusion according to Langendorff (1895) 7 as follows: the rabbits were injected with heparin (1000 units/kg) into the ear vein and 30 min later, the rabbits were sacrificed and the heart with at least 1 cm of attached aorta was removed as quickly as possible and placed in a dish of Lock-Ringer solution at 37º. The aorta was cut just below the point where it divides and the heart was transferred to the perfusion apparatus which contains two bottles, one for the unmedicated perfusion fluid and the second for the perfusion fluid that contains the required concentration of digoxin, Cryptostegia extract and cryptostigmin II. The aorta was tied onto the glass cannula and the perfusion fluid was an oxygenated lock. Ringer solution was warmed to 37º by means of a water jaket adjusted at 38º. Each figure represents the mean five experiments ± standard error.
The rate of flow of the perfusion fluid was kept constant at 3 ml/min by adjusting the pressure exerted on the fluid by means of a mercury manometer connected to the perfusion system. A thread was attached to the ventricle by a hook and the other end of the thread was passed over pulley wheels and was attached to the displacement transducer connected to the Oscillograph 400 2C. The contractions of the perfused hearts were recorded at a constant chart speed. Normal contraction was recorded during a period of 20 min until it was stabilized and become consistent. Then, the Lock-Ringer's solution containing the definite concentrations of the investigated samples was started to perfuse the hearts and recording the myocardial contractility every 5 min for a period of 30 min. The percentage change in the amplitude of normal myocardial contractility after perfusion with the tested samples was calculated. The results are given in Table 3 .
Determination of the median lethal dose
The median lethal dose (LD 50 ) and its 95% fiducial limits were calculated for Cryptostegia extract and cryptostigmin II. Groups of 6 male adult albino mice (20-28 g each) housed under the same conditions were intraperitoneally injected with graded doses of the extract (10 mg. 20 mg. 40 mg and 80 mg) and cryptostigmin II (2 mg, 3 mg, 4 mg and 8 mg). The mortality was determined 24 hours later in each group of the animals. Then the LD 50 results (mg/kg) were recorded as follows: 21.37±3.52 for Cryptostegia extract and 5.75±0.82 for cryptostigmin II.
RESULTS AND DISCUSSION
The ethanolic extract of the leaves of C. grandiflora was defatted with n-hexane and CH 2 Cl 2 and the aqueous layer was subjected to a column chromatography of Diaion HP-20. The 40% methanol eluate was repeatedly chromatographed on columns of silica gel and HPLC to afford four glucosides (1) (2) (3) (4) . 1 H-NMR spectrum of compound (1) showed one anomeric proton for βglucopyranose at δ 4.96, four OCH 3 groups at δ 3.82 and the other signals are similar to those reported for Liriodendrin. 8 13 C-NMR spectrum revealed the presence of one anomeric carbon for β-glucopyranose at 102.9 ppm, four aromatic carbons at 104.7 and 104.8 ppm, and four methoxylated aromatic carbons at 153.9 ppm. 13 C-NMR spectrum for the aglycone revealed the upfield shift of C-4`and c-4``, the upfield shifts of the other aromatic carbons and the other signals are very similar to those reported for (+)-syringaresinol. 9 This compound was previously isolated from the bark of Eucommia ulmoides Oliv. (Eucommiaceae). 10 Each figure represents the mean five experiments ± standard error. * Significant difference (P < 0.01) Vs control values. 1 H-NMR spectrum for compound (2) showed multiplet signal at δ 5.41 for 2H at positions 2 and 3; quartet signal at δ 1.91 J= 7.2 Hz for 2H at positions 4 and 5, triplet signal at δ 0.81 J= 7.6 Hz for 3H at position 6 and a doublet signal at δ 4.84, J= 7.8 Hz for anomeric proton.
The 13 C-NMR spectrum revealed the presence of twelve carbon atoms, six of them were at δ 104.7, 75.2, 78.5, 71.7, 78.6 and 62.8 which are characterisitc for β-glucopyranoside and the other six carbon atoms were characteristic for the presence of olefinic carbons between C-3 and C-4 at δ 133.5 and 125.5, in addition to oxygenated methine carbon at δ 69.3 corresponding to C-1 and at δ 20.8 corresponding to C-5 and one signal for methyl group at δ 14.3 ppm. It can be concluded that the structure is in full agreement with that reported for (Z)-3-hexenyl β-D-glucopyranoside. 11 The molecular formula of compound 3 was deduced as C 19 H 20 O 9 from HR FAB-MS spectrometry (see experimental section). The The 1 H-NMR spectrum of compound (4) exhibited four singlet methyl signals at δ 1.06 (3H) at 13, 1.48 (3H) at 11 or 12, 1.50 (3H) at 11 or 12 and 2.17 (3H) at 10, the last one being due to a methyl ketone. An anomeric proton signal at δ 5.09 (1H, d, J= 7.6 Hz) and an olefinic proton signal at δ 5.87 (1H, s) at 8. 13 C-NMR spectrum showed the presence of two carbinol carbon signals at 71.8 (d) and 71.2 (s). The former was shifted downfield by 6.2 ppm in 13 C-NMR spectrum of the aglycone and the later shifted downfield by only 1.0 ppm., this indicated the presence of glucosidation at position C-3.
These results led us to conclude that, the structure is in full agreement with that reported for Icariside B 1 . 16, 17 The structure determination was based on comparison of their physical chemical and spectral data ( 1 H, 13 The cardiotonic activity of Cryptostigmin II, the major cardenolide previously isolated from the leaves of C. grandiflora as well as the plant extract were investigated in comparison with digoxin. From the data reported in Table  2 , the intravenous administration of different doses of digoxin, C. grandiflora extract and Cryptostigmin II showed no change in the arterial blood pressure during the period of investigation (90 min). On the other hand, the intravenous administration of digoxin in doses of 1.0 and 1.5 mg/kg decreased the heart rate of rabbits. This reduction was started after 15 min of administration (Table 3) . From the results reported in the same Table, no change in the heart rate was observed after administration of the extract in doses of 2.5 and 5 mg/kg but the decrease in the heart rate was obvious at a dose of 7.5 mg/kg of the extract after 15 min of the intravenous administration. Moreover, no change in the heart rate was observed with doses of 0.5 and 1.0 mg/kg of Cryptostigmin II, but a significant decrease in the heart rate was clear when the dose increased to 1.5 m/kg after 15 min of administration. On the other hand, recording the contractility of the isolated perfused rabbit's heart every 5 min for a period of 30 min showed that digoxin produced no change at a concentration level of 0.25 mg/ml while the increase in the contractility was observed when the concentration levels were inreased to 0.5 and 1.0 mg/ml during the investigation period (Table 4 ). From the same Table, it's evident that the extract didn't exhibit any effect on the contractility at a concentration level of 2.5 mg/ml while it increased the contractility significantly when the concentration levels were increased to 5.0 and 7.5 mg/ml Cryptostigmin II revealed significant increase in the contractility at a concentration level of 1 mg/ml that is more potent than that of digoxin at the same concentration level after 15 and 30 min of administration. 
